| Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2019: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2018: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2017: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2016: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
|
|---|
| Outline of Final Research Achievements |
We conducted a multicenter, collaborative, longitudinal observational study among 200 patients with advanced lung cancer and their caregivers. Results showed that: 1) 54% and 44% of patients correctly understood that their cancer was incurable and that the goal of chemotherapy was not to completely cure the cancer, respectively; 2) patients who were explained the repeatedly incurable nature of their cancer demonstrated a more accurate understanding of their prognosis compared to those who were only explained once; 3) patients with accurate prognostic understanding had a significantly lower preference for life-prolonging treatments; and 4) the presence or absence of discussions regarding end-of-life care was not associated with patients' quality of life, depression, or actual end-of-life care. Based on the results of this study, the importance of conducting iterative and ongoing end-of-life discussions has been suggested.
|
